Should We Change the Target of Therapy in Pulmonary Hypertension?

Despite the evolution of drug therapy in pulmonary arterial hypertension and the more aggressive treatment approach according to the guidelines, patients continue to have unacceptable mortality rates. Furthermore, specific drug therapy alone in chronic thromboembolic pulmonary hypertension also does...

Descripción completa

Detalles Bibliográficos
Autores principales: Karyofyllis, Panagiotis, Demerouti, Eftychia, Habibis, Pavlos, Apostolopoulou, Styliani, Tsetika, Eleftheria-Garyfallia, Tsiapras, Dimitrios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10221333/
https://www.ncbi.nlm.nih.gov/pubmed/37240847
http://dx.doi.org/10.3390/life13051202

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10221333/
https://www.ncbi.nlm.nih.gov/pubmed/37240847
http://dx.doi.org/10.3390/life13051202

Ejemplares similares